(6-((4-(benzo[d]thiazol-5-yl)-5-methylpyrimidin-2-yl)amino)pyridin-3-yl)(4-ethylpiperazin-1-yl)methanone

ID: ALA5279534

Max Phase: Preclinical

Molecular Formula: C24H25N7OS

Molecular Weight: 459.58

Names and Identifiers

Canonical SMILES:  CCN1CCN(C(=O)c2ccc(Nc3ncc(C)c(-c4ccc5scnc5c4)n3)nc2)CC1

Standard InChI:  InChI=1S/C24H25N7OS/c1-3-30-8-10-31(11-9-30)23(32)18-5-7-21(25-14-18)28-24-26-13-16(2)22(29-24)17-4-6-20-19(12-17)27-15-33-20/h4-7,12-15H,3,8-11H2,1-2H3,(H,25,26,28,29)

Standard InChI Key:  QEWNDBARGCMPNH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -0.3664   -3.0861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3664   -2.2611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3508   -1.8536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0621   -2.2691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7818   -1.8608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7818   -1.0370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4982   -0.6280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4982    0.1969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2136    0.6085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2136    1.4339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5009    1.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5009    2.6727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7854    1.4361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0709    1.8486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0709    2.6736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3564    3.0861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3579    2.6736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1422    2.9286    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6273    2.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1422    1.5935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3579    1.8484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3564    1.4360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7854    0.6108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0704   -0.6215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3508   -1.0299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0783   -1.8440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7980   -2.2513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5036   -1.8317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5036   -1.0048    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2136   -0.5848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2136    0.2401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7840   -0.5973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0783   -1.0169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 17  1  0
 21 22  2  0
 22 14  1  0
 13 23  2  0
 23  8  1  0
  6 24  1  0
 24 25  2  0
 25  3  1  0
  2 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
 32 33  1  0
 33 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5279534

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 459.58

Molecular Weight (Monoisotopic): 459.1841

AlogP: 3.98

#Rotatable Bonds: 5

Polar Surface Area: 87.14

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.86

CX Basic pKa: 7.04

CX LogP: 3.73

CX LogD: 3.57

Aromatic Rings: 4

Heavy Atoms: 33

QED Weighted: 0.48

Np Likeness Score: -1.95

References

1. Yuan K, Shen H, Zheng M, Xia F, Li Q, Chen W, Ji M, Yang H, Zhuang X, Cai Z, Min W, Wang X, Xiao Y, Yang P..  (2023)  Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer.,  66  (6): [PMID:36800260] [10.1021/acs.jmedchem.3c00106]

Source

Source(1):

• Scientific Literature